Next Generation Sequencing (NGS)-based Sample-to-Report Solution

Overview

The Coordinating Entity requires a Product that meets or exceeds the following requirements that the Supplier is to provide: The solution for CLL must be an all-in-one NGS-based assay for the analysis and stratification of CLL cases including identification of the following elements: IGH rearrangements, IGH clonality, and IGHV SHM (somatic hypermutation); SNVs, indels, and CNVs for multiple genes including BCL2,...

Your Fit

Set your profile preferences to see how this opportunity fits your regions, industries, and keywords.

Key Requirements

• Review source documents for extracted requirements.

Recommended Next Steps

• Review the full source package and any addenda
• Check your team's credentials against the evaluation criteria
• Set deadline reminders and internal milestones